Stifel Nicolaus analyst Jonathan Block assigned a Buy rating to Align Tech (ALGN – Research Report) today and set a price target of $275.00.

Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market opens on Wednesday, January 29, 2025. The company will host a conference call ...

Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...

Stifel Nicolaus analyst Stephen Willey has maintained their neutral stance on EXEL stock, giving a Hold rating today.Invest with Confidence: ...

Xponential Fitness, Inc. (NYSE:XPOF – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten ...

Shares of Hut 8 Corp. (NASDAQ:HUT – Get Free Report) have earned an average recommendation of “Buy” from the nine brokerages ...

Dr. Anna Wu, Founder of ImaginAb, commented, We are very pleased that Telix recognizes the potential of our novel biological technology platform including enabling Telix to explore new disease areas ...

Despite a 15% drop in the SPDR S&P Biotech ETF, insider buying presents opportunities. Read why these small and mid-cap ...

Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Stifel analysts increased their price target for Zimmer Biomet Holdings Inc (NYSE:ZBH) shares from $130.00 to $138.00, while reiterating a Buy rating on the stock. The firm expressed confidence in the ...

Stifel analysts maintained their Buy rating on Carnival Corporation (NYSE:CCL) shares, with a steady price target of $34.00. According to InvestingPro data, 12 analysts have recently revised their ...

Following the cancellation of the repurchased shares, the Company will have no ordinary shares in treasury and 243,801,985 ordinary shares in issue. Therefore the total voting rig ...